Pluristem Therapeutics Inc (PSTI)

1.37 ↓0.13 (-8.67%)
As of Market Close on May 24th, 2022.

PSTI Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $1.37 - $4.36
  • Market Capitalization: $48.52M
  • Short Percentage: 0%
  • Target Price: $7.17
  • Shares Outstanding: 32.35M
  • Next Earnings: Feb 7
View More Stats

Catalysts

DateCategoryCatalyst
2022-02-07
Earnings

PSTI released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $1.78 Close: +0.85% Next Day: +0.28% Next Week: -6.48% View More
0 Comments Share
Help your fellow traders

Company Info

Website: https://www.pluristem.com
Address: Building No. 5, Haifa, Israel, 3508409
Sector: Healthcare
Industry: Biotechnology
Full time employees: 153

Stock Details

  • Current Price: $1.37
  • 52-Week Low: $1.37
  • 52-Week High: $4.36
  • Most Recent Quarter: 2022-03-31
  • Shares Float: 27.68M
  • Shares Outstanding: 32.35M
  • Market Capitalization: $48.52M
  • Next Earnings Date: 2022-02-07

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 0.00%

The short interest for Pluristem Therapeutics Inc is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 81.48%
Insiders: 7.28%
Instutitions: 11.24%

Analyst Target Price

7.17

Pluristem Therapeutics Inc is currently $5.67 below Wallstreet Analysts' price target.

Yesterday's Volume

121,357

Interest in Pluristem Therapeutics Inc has been trending up. The average daily volume in the past 14 days is 87,723.

Discussions

Please log in or register to share your thoughts.

bullorbear3/31/22 03:52pm

$PSTI TRUST THE PROCESS! BUY AND HOLD! OUR TIME IS COMING$$$

0 Like Report
bulls_only1/8/22 03:40pm

$PSTI Shorts talk the talk but cant walk the walk

0 Like Report
born_to_be_kob12/3/21 08:03pm

$PSTI when this finally break out we could see huge upside

0 Like Report